Inhibition of mTOR signaling in Parkinson's disease prevents L-DOPA-induced dyskinesia.
about
Serotonin and dopamine protect from hypothermia/rewarming damage through the CBS/H2S pathwayRule-based cell systems model of aging using feedback loop motifs mediated by stress responses5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophreniaRibosomal Protein S6 Phosphorylation in the Nervous System: From Regulation to FunctionErythropoietin: new directions for the nervous systemCutting through the complexities of mTOR for the treatment of strokePharmacological Treatments Inhibiting Levodopa-Induced Dyskinesias in MPTP-Lesioned Monkeys: Brain Glutamate Biochemical CorrelatesShedding new light on neurodegenerative diseases through the mammalian target of rapamycinConsolidation and translation regulationDriving neural regeneration through the mammalian target of rapamycinTargeting β-arrestin2 in the treatment of L-DOPA-induced dyskinesia in Parkinson's disease.Translation initiator EIF4G1 mutations in familial Parkinson diseaseDopamine receptors - IUPHAR Review 13Roles of fragile X mental retardation protein in dopaminergic stimulation-induced synapse-associated protein synthesis and subsequent alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-4-propionate (AMPA) receptor internalizationStriatal cholinergic interneurons display activity-related phosphorylation of ribosomal protein S6Requirement of Mammalian target of rapamycin complex 1 downstream effectors in cued fear memory reconsolidation and its persistence.Parallel dopamine D1 receptor activity dependence of l-Dopa-induced normal movement and dyskinesia in mice.Dysfunctional dopaminergic neurotransmission in asocial BTBR mice.Dopamine D2 receptors gate generalization of conditioned threat responses through mTORC1 signaling in the extended amygdala.Distinct changes in cAMP and extracellular signal-regulated protein kinase signalling in L-DOPA-induced dyskinesia.Maladaptive striatal plasticity in L-DOPA-induced dyskinesia.Identification of key pathways and transcription factors related to Parkinson disease in genome wide.Amelioration of behavioral abnormalities in BH(4)-deficient mice by dietary supplementation of tyrosine.Hot topics in aging research: protein translation and TOR signaling, 2010A Role for Mitogen- and Stress-Activated Kinase 1 in L-DOPA-Induced Dyskinesia and ∆FosB ExpressionDopaminergic tone regulates transient potassium current maximal conductance through a translational mechanism requiring D1Rs, cAMP/PKA, Erk and mTOR.Spatial and cellular characterization of mTORC1 activation after spinal cord injury reveals biphasic increase mainly attributed to microglia/macrophages.Mammalian target of rapamycin: hitting the bull's-eye for neurological disorders.Haloperidol regulates the state of phosphorylation of ribosomal protein S6 via activation of PKA and phosphorylation of DARPP-32L-DOPA-Induced Dyskinesia and Abnormal Signaling in Striatal Medium Spiny Neurons: Focus on Dopamine D1 Receptor-Mediated Transmission.An emerging role for the Mammalian target of rapamycin in "pathological" protein translation: relevance to cocaine addiction.Differential involvement of Ras-GRF1 and Ras-GRF2 in L-DOPA-induced dyskinesiaDeconvoluting mTOR biologyAnatomy of Graft-induced Dyskinesias: Circuit Remodeling in the Parkinsonian StriatumHyperphosphorylation of ribosomal protein S6 predicts unfavorable clinical survival in non-small cell lung cancerDopamine- and cAMP-regulated phosphoprotein of 32-kDa (DARPP-32)-dependent activation of extracellular signal-regulated kinase (ERK) and mammalian target of rapamycin complex 1 (mTORC1) signaling in experimental parkinsonism.Dopamine D2 receptor and β-arrestin 2 mediate Amyloid-β elevation induced by anti-parkinson's disease drugs, levodopa and piribedil, in neuronal cellsThe role of mTOR signaling pathway in spinal cord injury.Modulation of striatal projection systems by dopamine.A Critical Kinase Cascade in Neurological Disorders: PI 3-K, Akt, and mTOR.
P2860
Q21560942-81983C33-897E-4AF1-BD4E-59BF2CCA1440Q21563497-F32BE70A-6C9A-4293-8927-EAE644427F7CQ24299992-23FA37BD-B294-4379-AF34-9F90659B2350Q26770762-C5CC0054-1ABA-4FE7-8B83-468A405BA056Q26828425-2044E798-BFE3-4144-8570-ACDE374506ADQ26851291-34084F2F-3D05-4874-921C-09112880A8B5Q26852311-4C6344A2-FB21-4B7F-81B3-803471E2E21AQ27015640-154ABAF0-9D9D-4FE8-AFE5-084990B86ACFQ27025904-025E170D-6179-4E83-8021-3359B30590F4Q27027516-FD5AF1B9-BCE8-43A8-B11B-DA7EE269D129Q27324174-3A0E44D2-5C19-462B-A995-9665197ABA4CQ28247679-AD724A17-3D96-4F97-8DB1-267DDDED0143Q28256783-EF5ACEA4-53FD-427D-9AED-A98DE9A2630DQ28396707-CE13A593-9271-460D-AC89-25C8ECA17045Q28484644-36EDCCC7-3B53-4AD8-8E85-04D6A257DC3FQ28508309-53AC0E94-323A-4D48-8EFA-596FC1007581Q30538394-750CE6C9-0B9E-4AFF-81A3-0E2DBC5AEE1CQ30586693-66F63E0C-613F-4142-9844-54CC413A6725Q30828059-1B12C321-6D0B-4C52-8530-5516B35F4967Q30988635-2B5259D5-BEC4-4D37-8907-BBCB0F698238Q34094008-10C8C4E9-63D1-4816-8FBA-AEAD09B74005Q34449994-2903F060-4603-44E3-9EC8-708354029FBAQ34663995-373A68F1-3215-4CB1-8FFF-EDB8FA5D14C0Q34669340-6F3843A1-5B84-4198-82FA-584863D90EE1Q35024117-ECA1C36A-7658-4EB3-9C0F-81F11EDB824AQ35041795-1C2E027F-1AFF-439B-B793-7112CCBC861BQ35140800-3A4524D8-A899-41E8-B8F3-0EC113DB177DQ35157985-E6E49DBE-016D-4898-8165-8F5E1191E203Q35356825-FB7FB6A7-0A05-4C48-A903-7AFCDAABAA11Q35424424-52170BD0-4F87-4072-AE38-CC130962D1E8Q35738367-698A22D5-F29A-45D6-AD55-CB2225772BD2Q35777273-FEE36F7C-626A-4837-A10F-A09D44D4D2C5Q35801388-0557D8A4-0358-4162-937D-EBC7D3AE4B09Q36034592-4D9618BC-4851-4B7D-BDC4-8D15D670EBF8Q36200159-032A6D1B-8723-4342-B768-EB52114A8E57Q36201811-00D63DBF-015E-4FD4-B141-C5F5C0FE155FQ36295526-541F6AB7-A909-4A8B-8E0C-D9D75222A352Q36304099-ED3BF13D-1F61-48ED-BBA4-ED07AAE16D1AQ36367283-7E0A7D17-C9E4-4F21-ACE6-3854C1C9F83DQ36379761-8AACE599-7BAB-4A83-A78E-861A15E95D89
P2860
Inhibition of mTOR signaling in Parkinson's disease prevents L-DOPA-induced dyskinesia.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Inhibition of mTOR signaling in Parkinson's disease prevents L-DOPA-induced dyskinesia.
@en
Inhibition of mTOR signaling in Parkinson's disease prevents L-DOPA-induced dyskinesia.
@nl
type
label
Inhibition of mTOR signaling in Parkinson's disease prevents L-DOPA-induced dyskinesia.
@en
Inhibition of mTOR signaling in Parkinson's disease prevents L-DOPA-induced dyskinesia.
@nl
prefLabel
Inhibition of mTOR signaling in Parkinson's disease prevents L-DOPA-induced dyskinesia.
@en
Inhibition of mTOR signaling in Parkinson's disease prevents L-DOPA-induced dyskinesia.
@nl
P2093
P1433
P1476
Inhibition of mTOR signaling in Parkinson's disease prevents L-DOPA-induced dyskinesia.
@en
P2093
Emanuela Santini
Gilberto Fisone
Myriam Heiman
P356
10.1126/SCISIGNAL.2000308
P577
2009-07-21T00:00:00Z